Animal Vaccines Market by Product and Animal Type - Global Industry Analysis & Forecast to 2027

Published On : April 2019 Pages : 180 Category: Pharmaceuticals Report Code : HC043058

Animal Vaccines Market by Product Type (Recombinant Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines) Animal Type (Cattle, Dogs, Fish, Pigs, Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis
Animal vaccines control the transmission maladies, along these lines giving security to Animal and human wellbeing, which is fundamental thinking about the open reliance on Animal. Animals fill in as an essential wellspring of sustenance, meat, milk, protein, and other business items, for example, calfskin and fleece. Most usually utilized veterinary vaccines incorporate rabies immunizations, foot and mouth sicknesses immunizations, and equine flu infection vaccines, which keep the transmission of irresistible operators by mirroring the normally obtained invulnerability. Steady advancement of immunizations is fundamental with ascend in rise of various animal maladies.

Drivers and Restraints

The animal vaccines market is to develop at an unfaltering pace because of increment in pet proprietorship in created nations and ascend in number of dairy cattle and poultry in creating nations. Besides, flood in venture for R&D of immunizations, which repress the development of anti-microbial safe animal helps the animal vaccines market growth. However, absence of animal wellbeing mindfulness and plausibility of unfavorable effect on veterinary antibodies on human and other creature wellbeing can control the development for animal vaccines market advertise. Moreover, the progressed in antibody items and creation of creature immunizations for half and half animals can open new road for the development of animal immunizations advertise.

Regional Insights

North America represented the most noteworthy income in the worldwide animal vaccines advertise. This is owing to the high appropriation of friendly animals; ascend in the utilization of meat and milk, and developing mindfulness in regards to the advantages of utilizing animal vaccines.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Vaxxinova
  • Romvac
  • Sanofi S.A.
  • Ceva Santé Animale
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Anicon Labor GmbH
  • Biovac
  • Merial
  • Pfizer

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Animal Vaccines Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o    Recombinant Vaccines

o    Conjugate Vaccines

o    Inactivated Vaccines

o    Subunit Vaccines

o    Attenuated Vaccines

o    Toxoid Vaccines

o    DNA Vaccines

·         Animal Vaccines Market, By Animal type, Estimates and Forecast, 2017-2027 ($Million)

o    Cattle

o    Dogs

o    Fish

o    Pigs

o    Others

·         Animal Vaccines Market, By Key Players

o    Vaxxinova

o    Romvac

o    Sanofi S.A.

o    Ceva Santé Animale

o    Zoetis Inc.

o    Merck & Co., Inc.

o    Anicon Labor GmbH

o    Biovac

o    Merial

o    Pfizer

·         Animal Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Animal Vaccines Market, By Country

o    U.S. Animal Vaccines Market

o    Canada Animal Vaccines Market

o    Mexico Animal Vaccines Market

o    Europe

§  Europe Animal Vaccines Market, By Country

o    Germany Animal Vaccines Market

o    UK Animal Vaccines Market

o    France Animal Vaccines Market

o    Russia Animal Vaccines Market

o    Italy Animal Vaccines Market

o    Rest of Europe Animal Vaccines Market

o    Asia-Pacific

§  Asia-Pacific Animal Vaccines Market, By Country

o    China Animal Vaccines Market

o    Japan Animal Vaccines Market

o    South Korea Animal Vaccines Market

o    India Animal Vaccines Market

o    Southeast Asia Animal Vaccines Market

o    Rest of Asia-Pacific Animal Vaccines Market

o    South America

§  South America Animal Vaccines Market

o    Brazil Animal Vaccines Market

o    Argentina Animal Vaccines Market

o    Columbia Animal Vaccines Market

o    Rest of South America Animal Vaccines Market

o    Middle East and Africa

§  Middle East and Africa Animal Vaccines Market

o    Saudi Arabia Animal Vaccines Market

o    UAE Animal Vaccines Market

o    Egypt Animal Vaccines Market

o    Nigeria Animal Vaccines Market

o    South Africa Animal Vaccines Market

o    Rest of MEA Animal Vaccines Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Animal Vaccines Market, By Product Type

5.1.     Introduction

5.2.     Global Animal Vaccines Revenue and Market Share by Product Type (2017-2027)

5.2.1.  Global Animal Vaccines Revenue and Revenue Share by Product Type (2017-2027)

5.3.     Recombinant Vaccines

5.3.1.  Global Recombinant Vaccines Revenue and Growth Rate (2017-2027)

5.4.     Conjugate Vaccines

5.4.1.  Global Conjugate Vaccines Revenue and Growth Rate (2017-2027)

5.5.     Inactivated Vaccines

5.5.1.  Global Inactivated Vaccines Revenue and Growth Rate (2017-2027)

5.6.     Subunit Vaccines

5.6.1.  Global Subunit Vaccines Revenue and Growth Rate (2017-2027)

5.7.     Attenuated Vaccines

5.7.1.  Global Attenuated Vaccines Revenue and Growth Rate (2017-2027)

5.8.     Toxoid Vaccines

5.8.1.  Global Toxoid Vaccines Revenue and Growth Rate (2017-2027)

5.9.     DNA Vaccines

5.9.1.  Global DNA Vaccines Revenue and Growth Rate (2017-2027)

6.       Animal Vaccines Market, By Animal Type

6.1.     Introduction

6.2.     Global Animal Vaccines Revenue and Market Share by Animal Type (2017-2027)

6.2.1.  Global Animal Vaccines Revenue and Revenue Share by Animal Type (2017-2027)

6.3.     Cattle

6.3.1.  Global Cattle Revenue and Growth Rate (2017-2027)

6.4.     Dogs

6.4.1.  Global Dogs Revenue and Growth Rate (2017-2027)

6.5.     Fish

6.5.1.  Global Fish Revenue and Growth Rate (2017-2027)

6.6.     Pigs

6.6.1.  Global Pigs Revenue and Growth Rate (2017-2027)

6.7.     Others

6.7.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Animal Vaccines Market, By Region

7.1.     Introduction

7.2.     Global Animal Vaccines Revenue and Market Share by Regions

7.2.1.  Global Animal Vaccines Revenue by Regions (2017-2027)

7.3.     North America Animal Vaccines by Countries

7.3.1.  North America Animal Vaccines Revenue and Growth Rate (2017-2027)

7.3.2.  North America Animal Vaccines Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Animal Vaccines by Countries

7.4.1.  Europe Animal Vaccines Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Animal Vaccines Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Animal Vaccines by Countries

7.5.1.  Asia-Pacific Animal Vaccines Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Animal Vaccines Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Animal Vaccines by Countries

7.6.1.  South America Animal Vaccines Revenue and Growth Rate (2017-2027)

7.6.2.  South America Animal Vaccines Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Animal Vaccines by Countries

7.7.1.  Middle East and Africa Animal Vaccines Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Animal Vaccines Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Vaxxinova

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Romvac

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Sanofi S.A.

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Ceva Santé Animale

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Zoetis Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Merck & Co., Inc.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Anicon Labor GmbH

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Biovac

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Merial

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Pfizer

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Global Animal Vaccines Market Competition, by Manufacturer

9.1.     Global Animal Vaccines Financial Overview by Manufacturer (2017-2017)

9.2.     Global Animal Vaccines Price By Region (2017-2017)

9.3.     Top 5 Animal Vaccines Manufacturer Market Share

9.4.     Market Competition Trend

10.    Animal Vaccines Market Forecast (2017-2027)

10.1. Global Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Animal Vaccines Market Forecast by Regions (2017-2027)

10.2.1.      North America Animal Vaccines Market Forecast (2017-2027)

10.2.1.1. United States Animal Vaccines Market Forecast (2017-2027)

10.2.1.2. Canada Animal Vaccines Market Forecast (2017-2027)

10.2.1.3. Mexico Animal Vaccines Market Forecast (2017-2027)

10.2.2.      Europe Animal Vaccines Market Forecast (2017-2027)

10.2.2.1. Germany Animal Vaccines Market Forecast (2017-2027)

10.2.2.2. France Animal Vaccines Market Forecast (2017-2027)

10.2.2.3. UK Animal Vaccines Market Forecast (2017-2027)

10.2.2.4. Russia Animal Vaccines Market Forecast (2017-2027)

10.2.2.5. Italy Animal Vaccines Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Animal Vaccines Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Animal Vaccines Market Forecast (2017-2027)

10.2.3.1. China Animal Vaccines Market Forecast (2017-2027)

10.2.3.2. Japan Animal Vaccines Market Forecast (2017-2027)

10.2.3.3. Korea Animal Vaccines Market Forecast (2017-2027)

10.2.3.4. India Animal Vaccines Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Animal Vaccines Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Animal Vaccines Market Forecast (2017-2027)

10.2.4.      South America Animal Vaccines Market Forecast (2017-2027)

10.2.4.1. Brazil Animal Vaccines Market Forecast (2017-2027)

10.2.4.2. Argentina Animal Vaccines Market Forecast (2017-2027)

10.2.4.3. Columbia Animal Vaccines Market Forecast (2017-2027)

10.2.4.4. Rest of South America Animal Vaccines Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Animal Vaccines Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Animal Vaccines Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Animal Vaccines Market Forecast (2017-2027)

10.2.5.3. Egypt Animal Vaccines Market Forecast (2017-2027)

10.2.5.4. Nigeria Animal Vaccines Market Forecast (2017-2027)

10.2.5.5. South Africa Animal Vaccines Market Forecast (2017-2027)

10.2.5.6. Turkey Animal Vaccines Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Animal Vaccines Market Forecast (2017-2027)

10.3. Animal Vaccines Market Forecast by Product Type (2017-2027)

10.3.1.      Animal Vaccines Forecast by Product Type (2017-2027)

10.3.2.      Animal Vaccines Market Share Forecast by Product Type (2017-2027)

10.4. Animal Vaccines Market Forecast by Animal Type (2017-2027)

10.4.1.      Animal Vaccines Forecast by Animal Type (2017-2027)

10.4.2.      Animal Vaccines Market Share Forecast by Animal Type (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Animal Vaccines Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Animal Vaccines Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Recombinant Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Conjugate Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Inactivated Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Subunit Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Attenuated Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Toxoid Vaccines Revenue and Growth Rate (2017-2018)
Figure Global DNA Vaccines Revenue and Growth Rate (2017-2018)
Table Global Animal Vaccines Revenue and Revenue Share by Animal Type (2017-2018)
Figure Global Cattle Revenue and Growth Rate (2017-2018)
Figure Global Dogs Revenue and Growth Rate (2017-2018)
Figure Global Fish Revenue and Growth Rate (2017-2018)
Figure Global Pigs Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Animal Vaccines Revenue by Regions (2017-2018)
Figure North America Animal Vaccines Growth Rate (2017-2018)
Figure North America Animal Vaccines Revenue and Growth Rate (2017-2018)
Figure North America Animal Vaccines by Countries (2017-2018)
Figure North America Animal Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure United States Animal Vaccines Growth Rate (2017-2018)
Figure United States Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Animal Vaccines Growth Rate (2017-2018)
Figure Canada Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Animal Vaccines Growth Rate (2017-2018)
Figure Mexico Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Animal Vaccines Growth Rate (2017-2018)
Figure Europe Animal Vaccines Revenue and Growth Rate (2017-2018)
Figure Europe Animal Vaccines by Countries (2017-2018)
Figure Europe Animal Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Germany Animal Vaccines Growth Rate (2017-2018)
Figure Germany Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Animal Vaccines Growth Rate (2017-2018)
Figure France Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Animal Vaccines Growth Rate (2017-2018)
Figure UK Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Animal Vaccines Growth Rate (2017-2018)
Figure Russia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Animal Vaccines Growth Rate (2017-2018)
Figure Italy Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Animal Vaccines Growth Rate (2017-2018)
Figure Rest of Europe Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Animal Vaccines Growth Rate (2017-2018)
Figure Asia-Pacific Animal Vaccines Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Animal Vaccines by Countries (2017-2018)
Figure Asia-Pacific Animal Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure China Animal Vaccines Growth Rate (2017-2018)
Figure China Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Animal Vaccines Growth Rate (2017-2018)
Figure Japan Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Animal Vaccines Growth Rate (2017-2018)
Figure Korea Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Animal Vaccines Growth Rate (2017-2018)
Figure India Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Animal Vaccines Growth Rate (2017-2018)
Figure Southeast Asia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Animal Vaccines Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Animal Vaccines Growth Rate (2017-2018)
Figure South America Animal Vaccines Revenue and Growth Rate (2017-2018)
Figure South America Animal Vaccines by Countries (2017-2018)
Figure South America Animal Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Animal Vaccines Growth Rate (2017-2018)
Figure Brazil Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Animal Vaccines Growth Rate (2017-2018)
Figure Argentina Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Animal Vaccines Growth Rate (2017-2018)
Figure Columbia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Animal Vaccines Growth Rate (2017-2018)
Figure Rest of South America Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Animal Vaccines Growth Rate (2017-2018)
Figure Middle East and Africa Animal Vaccines Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Animal Vaccines by Countries (2017-2018)
Figure Middle East and Africa Animal Vaccines Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Animal Vaccines Growth Rate (2017-2018)
Figure Saudi Arabia Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Animal Vaccines Growth Rate (2017-2018)
Figure United Arab Emirates Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Animal Vaccines Growth Rate (2017-2018)
Figure Egypt Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Animal Vaccines Growth Rate (2017-2018)
Figure Nigeria Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Animal Vaccines Growth Rate (2017-2018)
Figure South Africa Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Animal Vaccines Growth Rate (2017-2018)
Figure Turkey Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Animal Vaccines Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Animal Vaccines Revenue (Millions USD) and Growth Rate (2017-2018)
Table Vaxxinova Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Romvac Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi S.A. Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ceva Santé Animale Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Zoetis Inc. Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co., Inc. Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Anicon Labor GmbH Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Biovac Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merial Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Animal Vaccines Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Animal Vaccines Market Share by Manufacturer
Figure Global Animal Vaccines Revenue and Market Share by Manufacturer
Table Global Animal Vaccines Price by Region (2017-2017)
Figure Top 5 Animal Vaccines Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Animal Vaccines Revenue (Millions USD) and Growth Rate (2018-2025)
Table Animal Vaccines Market Forecast by Regions (2018-2025)
Figure North America Animal Vaccines Market Forecast (2018-2025)
Figure United States Animal Vaccines Market Forecast (2018-2025)
Figure Canada Animal Vaccines Market Forecast (2018-2025)
Figure Mexico Animal Vaccines Market Forecast (2018-2025)
Figure Europe Animal Vaccines Market Forecast (2018-2025)
Figure Germany Animal Vaccines Market Forecast (2018-2025)
Figure France Animal Vaccines Market Forecast (2018-2025)
Figure UK Animal Vaccines Market Forecast (2018-2025)
Figure Russia Animal Vaccines Market Forecast (2018-2025)
Figure Italy Animal Vaccines Market Forecast (2018-2025)
Figure Rest of Europe Animal Vaccines Market Forecast (2018-2025)
Figure Asia-Pacific Animal Vaccines Market Forecast (2018-2025)
Figure China Animal Vaccines Market Forecast (2018-2025)
Figure Japan Animal Vaccines Market Forecast (2018-2025)
Figure Korea Animal Vaccines Market Forecast (2018-2025)
Figure India Animal Vaccines Market Forecast (2018-2025)
Figure Southeast Asia Animal Vaccines Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Animal Vaccines Market Forecast (2018-2025)
Figure South America Animal Vaccines Market Forecast (2018-2025)
Figure Brazil Animal Vaccines Market Forecast (2018-2025)
Figure Argentina Animal Vaccines Market Forecast (2018-2025)
Figure Columbia Animal Vaccines Market Forecast (2018-2025)
Figure Rest of South America Animal Vaccines Market Forecast (2018-2025)
Figure Middle East and Africa Animal Vaccines Market Forecast (2018-2025)
Figure Saudi Arabia Animal Vaccines Market Forecast (2018-2025)
Figure United Arab Emirates Animal Vaccines Market Forecast (2018-2025)
Figure Egypt Animal Vaccines Market Forecast (2018-2025)
Figure Nigeria Animal Vaccines Market Forecast (2018-2025)
Figure South Africa Animal Vaccines Market Forecast (2018-2025)
Figure Turkey Animal Vaccines Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Animal Vaccines Market Forecast (2018-2025)
Figure Global Animal Vaccines Forecast by Product Type (2018-2025)
Figure Global Animal Vaccines Market Share Forecast by Product Type (2018-2025)
Figure Global Animal Vaccines Forecast by Product Type (2018-2025)
Figure Global Animal Vaccines Forecast by Animal Type (2018-2025)
Figure Global Animal Vaccines Market Share Forecast by Animal Type (2018-2025)
Figure Global Animal Vaccines Forecast by Animal Type (2018-2025)

Please Note: Data related to the Companies are subject to Availability


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*